EUVIMEDOpdag EUVIMED
Crossref

Possible effects of plasminogen activator inhibitor‐1 on promoting angiogenesis through matrix metalloproteinase 9 in advanced mycosis fungoides

Taku Fujimura iD, Kentaro Ohuchi, Tetsuya Ikawa, Yumi Kambayashi, Ryo Amagai, Sadanori Furudate, Yoshihide Asano

Hematological Oncology · 2024

DOI: 10.1002/hon.3244 ↗

At a glance

Journal article in Hematological Oncology, 2024. Written by Taku Fujimura and 6 co-authors. Institution: Department of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan. Major MEDLINE topics: Mycosis Fungoides, Skin Neoplasms. Cited 4 times so far (Crossref); 27 references. Funded by: Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Mycosis fungoides (MF) progresses slowly before advancing to skin tumors followed by lymph node and visceral involvement. Among MF progression, stage IIB is an initial time point of tumor formation in MF. Since MF in tumor stage possess abundant blood vessels, it is important to evaluate the pro‐angiogenic factors before and after MF in stage IIB. In this report, we investigated pro‐angiogenic soluble factors in MF patients, as well as its pro‐angiogenetic effects on tumor cells and stroma cells. We first evaluated the serum levels of pro‐angiogenic factors in 9 MF patients without tumor formation and 8 MF patients with tumor formation. Among them, the serum MMP‐9 and plasminogen activator inhibitors 1 (PAI‐1) was significantly increased in MF with tumor formation compared in MF without tumor formation, leading to favorable formation of human dermal microvascular endothelial cells tube networks. Moreover, PAI‐1 stimulation significantly increased the mRNA expression and protein production MMP‐9 on monocytes derived M2 macrophages and HUT‐78. Furthermore, since MMP‐9 production from tumor cells as well as stromal cells is suppressed by bexarotene, we evaluate the baseline serum pro‐angiogenic factors including MMP‐9 in 16 patients with advanced cutaneous T cell lymphoma treated with bexarotene. The serum levels of MMP‐2 and MMP‐9 was significantly increased in bexarotene non‐responded patients compared to responded patients. Our present study suggested the significance of MMP‐9 and PAI‐1 for the progression of MF stage toward to the tumor stage, and could be a therapeutic target in future.

Subjects

MeSH terms (MEDLINE)

Mycosis FungoidesSkin NeoplasmsHumansAngiogenesisBexaroteneEndothelial CellsMatrix Metalloproteinase 9Plasminogen Activator Inhibitor 1

Author keywords

MMP-9PAI-1bexarotenemycosis fungoidesstromal cells

Substances

BexaroteneMatrix Metalloproteinase 9Plasminogen Activator Inhibitor 1SERPINE1 protein, human

Authors and institutions

  • Department of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan.

ORCID profiles: Taku Fujimura

Funding

  • Japan Agency for Medical Research and Development
  • Japan Society for the Promotion of Science

Cite

APA

Fujimura, T., Ohuchi, K., Ikawa, T., Kambayashi, Y., Amagai, R., Furudate, S., & Asano, Y. (2024). Possible effects of plasminogen activator inhibitor‐1 on promoting angiogenesis through matrix metalloproteinase 9 in advanced mycosis fungoides. Hematological Oncology. https://doi.org/10.1002/hon.3244

Vancouver

Fujimura T, Ohuchi K, Ikawa T, Kambayashi Y, Amagai R, Furudate S, et al. Possible effects of plasminogen activator inhibitor‐1 on promoting angiogenesis through matrix metalloproteinase 9 in advanced mycosis fungoides. Hematological Oncology. 2024. doi:10.1002/hon.3244

BibTeX
@article{Fujimura2024,
  author = {Fujimura, Taku and Ohuchi, Kentaro and Ikawa, Tetsuya and Kambayashi, Yumi and Amagai, Ryo and Furudate, Sadanori and Asano, Yoshihide},
  title = {Possible effects of plasminogen activator inhibitor‐1 on promoting angiogenesis through matrix metalloproteinase 9 in advanced mycosis fungoides},
  journal = {Hematological Oncology},
  year = {2024},
  doi = {10.1002/hon.3244}
}
Start for free →